Chronic kidney disease in type 1 diabetes: translation of novel type 2 diabetes therapeutics to individuals with type 1 diabetes
Sridhar VS, Limonte CP, Groop PH, et al.
Diabetologia. Pub. online 6 Oct 2023.
Leggi
Blu
Le Breaking News di colore blu sono relative ad abstract di articoli originali di particolare rilevanza.
Contribution of intestinal triglyceride-rich lipoproteins to residual atherosclerotic cardiovascular disease risk in individuals with type 2 diabetes on statin therapy
Taskinen MR, Matikainen N, Björnson E, et al.
Diabetologia. Pub. online 29 Sep 2023.
Leggi
Comparison of intranasal and injectable glucagon administration among pediatric population responders
Wang YP, Bernatchez F, Chouinard-Castonguay S, et al.
Diabetes Technol Ther. Pub. online 26 Sep 2023.
Leggi
Early metformin in gestational diabetes: a randomized clinical trial
Dunne F, Newman C, Alvarez-Iglesias A, et al.
JAMA. 2023 Oct 3:e2319869.
Leggi
Antihypertensive and lipid-lowering medication adherence in young adults with youth-onset type 2 diabetes
Weinstock RS, Trief PM, Burke BK, et al.
JAMA Netw Open. 2023;6(10):e2336964.
Leggi
Association between timing and consistency of physical activity and type 2 diabetes: a cohort study on participants of the UK Biobank
Tian C, Bürki C, Westerman KE, Patel CJ
Diabetologia. Pub. online 20 Sep 2023.
Leggi
Long‐term effects of coronavirus disease 2019 on diabetes complications and mortality in people with diabetes: Two cohorts in the UK and Hong Kong
Wan EYF, Mathur S, Zhang R, et al.
Diabetes Obes Metab. Pub. online 21 Sep 2023.
Leggi
Risk of thyroid cancer associated with glucagon‐like peptide‐1 receptor agonists and dipeptidyl peptidase‐4 inhibitors in patients with type 2 diabetes: A population‐based cohort study
Bea S, Son H, Bae JH, et al.
Diabetes Obes Metab. Pub. online 21 Sep 2023.
Leggi
Mechanisms of weight loss-induced remission in people with prediabetes: a post-hoc analysis of the randomised, controlled, multicentre Prediabetes Lifestyle Intervention Study (PLIS)
Sandforth A, von Schwartzenberg RJ, Vazquez Arreola E, et al.
Lancet Diabetes Endocrinol. 2023;S2213-8587(23)00235-8.
Leggi
Semaglutide in patients with heart failure with preserved ejection fraction and obesity
Kosiborod MN, Abildstrøm SZ, Borlaug BA, et al.
N Engl J Med. 2023;389(12):1069-1084.
Leggi